Surgical Simulation Market is predicted to reach USD 1.5 billion at a CAGR of 14.42% during the forecast period 2024-2032

Market Research Future (MRFR) has published on the “Global surgical simulation Market”. The global surgical simulation market is projected to register a CAGR of 14.42% during the forecast period of 2024 to 2032.

Surgical Simulation Market Highlights

The global surgical simulation market is accounted to register a CAGR of 14.42% during the forecast period and is estimated to reach USD 1.5 billion by 2032.

The global surgical simulation market is experiencing significant growth, driven by a convergence of factors, with a particular emphasis on patient safety and its intersection with the burgeoning geriatric population. According to WHO By 2030, one in every six people on the planet will be 60 or older. At this point, the proportion of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. In an era where healthcare quality is paramount, surgical simulation stands out as a pivotal tool for enhancing the competence and skills of medical professionals, significantly contributing to heightened patient safety. This focus on patient safety is especially relevant given the global demographic shift toward an increasingly aging population. The rising number of elderly individuals worldwide is accompanied by a heightened prevalence of age-related health conditions necessitating surgical interventions. Surgical simulation plays a crucial role in training and preparing the healthcare workforce to meet the unique challenges and intricacies of geriatric surgery. By providing a controlled, risk-free training environment, simulation empowers medical students, residents, and seasoned surgeons to develop and refine their surgical skills without exposing elderly patients to avoidable risks. The increasing number of surgical procedures in various countries is a major factor driving up demand for surgical simulation systems.

Moreover, the increasing strategic partnerships also drive the market for surgical simulation. For instance, in May 2020 VirtaMed and Medical Microinstruments (Italy) partnership to improve surgeons' ability to perform complex robotic microsurgeries.

However, the lack of standardization is anticipated to hamper market growth. Nonetheless, it is anticipated that the regulatory support for surgical simulation is creating lucrative opportunities for the global surgical simulation market.

Key Players

MRFR recognizes the following companies as the key players in the global surgical simulation market Simulab Corporation (US), Surgical Science (Sweden), Mentice (Sweden), VirtaMed AG (Switzerland), 3-Dmed Learning Through Simulation (US), Laerdal Medical (Norway), Gaumard Scientific (US), Materialise (Belgium), Stratasys (Israel), CAE Inc. (Canada)Simulab Corporation (US), Surgical Science (Sweden), Mentice (Sweden), VirtaMed AG (Switzerland), 3-Dmed Learning Through Simulation (US), Laerdal Medical (Norway), Gaumard Scientific (US), Materialise (Belgium), Stratasys (Israel), CAE Inc. (Canada).

Segment Analysis

The global surgical simulation market has been segmented based on model type, function, application, and end user.

On the basis of model type, the global surgical simulation market is segmented into reality and virtual. The reality model type segment accounted for the largest market with a market share of over 60.26% in 2022, and the virtual model type segment is anticipated to be the fastest-growing for the forecast period of 2024–2032. This is due to the rapid popularity over the coming years on a global level, which can be linked to the advancements in VR technology. Accurate representation of realistic surgical scenarios by VR simulators is contributing to their rising popularity and driving surgical simulation market growth.

Based on function, the global Surgical Simulation market is segmented into medical training and medical device development. Medical training held the largest market share in 2022 and is anticipated to register the highest CAGR from 2024 to 2032. Medical training institutions have found that integrating laparoscopic simulation into their curriculum improves training outcomes and ultimately promotes better patient care.

On the basis of application, the global Surgical Simulation market is segmented into laparoscopic surgery, cardiac surgery, gynecological surgery, neurological surgery, endoscopic surgery, and others. The laparoscopic surgery segment accounted for the largest share in 2022 and is the fastest-growing segment during the forecast period. As it helps in reducing post operative pain, and helps in shorter hospital stays, and faster recovery. Moreover, it also provides patient safety and risk mitigation.

Based on end user, global Surgical Simulation market is segmented into hospitals, surgical centers, academic & research institutes, military organizations, and medical device companies. The hospitals segment accounted for the largest share in 2022 and is the fastest-growing segment during the forecast period. The majority of people prefer hospitals for advanced treatment of chronic diseases and surgical procedures such as general surgery, orthopedics, cardiac and thoracic surgery, and obstetric/gynecological surgery. These facilities offer patients cost-effective options and are equipped to handle a wide range of surgical interventions. Therefore, the increasing demand of surgical simulation from hospitals is driving the growth of the end user segment.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Surgical Simulation Market Research Report

Regional Analysis

The global Surgical Simulation market, based on region, has been divided into North America, Europe, Asia-Pacific, and Middle East & Africa. North America further includes US and Canada. Europe includes countries namely Germany, France, UK, Italy, Spain, and the Rest of Europe. The global Surgical Simulation market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. Moreover, the Rest of the World comprises of Middle East, Africa, and Latin America.

North America held the largest market share in terms of revenue in 2022 due to the presence of key market players in the region. Furthermore, the early adoption of advanced technologies and product innovation by market players further facilitated the growth of the market. For instance, in January 2020, ImmersiveTouch introduced ImmersiveView Surgical Plan for personalized VR surgical simulation. This product launch created competitive rivalry in the North America region, which fueled market growth in 2022.

Moreover, Europe shows significant growth during the forecast period due to the growing geriatric population. For instance, the British Heart Foundation has established a Strategy 2030 through which it is promoting the information about prevention and treatment of heart diseases and planning to increase its funding for better research. Such initiatives are expected to propel the demand for cardiac surgical simulators in the UK. Furthermore, presence of one of the renowned players namely Surgical Science (Sweden) also propels Europe region growth owing to offering NPWT in countries including Germany, the UK, France, Italy, Spain and others. Therefore, the increasing number of surgical procedures and the presence of renowned players are bolstering the growth of the European Surgical Simulation market.

Furthermore, the Asia-Pacific Surgical Simulation region market is the fastest growing and present lucrative growth opportunities for the global market due to increasing surgical procedures. Growing geriatric population, increased healthcare expenditure, high awareness about surgical simulation, and supportive government initiatives. The government of India mandated simulation-based training in all undergraduate programs. Such government initiatives will boost the growth of the Asia-Pacific market.

The Rest of the World region is comprised of the Middle East, Africa, and Latin America. The increasing focus on patient safety in the Middle East and Africa is increasing the demand for surgical simulation in the rest of the world. Moreover, the government initiatives to prevent surgical site infections in the region are propelling the growth of the surgical simulation market.

Key Findings of the Study

• The global Surgical Simulation market is expected to reach USD 1.5 billion by 2032, at a CAGR of 14.42% during the forecast period.


• The Europe region held the second largest market share of the global market, owing to growing geriatric population and the presence of renowned market players.


• Based on model type, the reality model type segment held the largest market with a market share of 71.40% in 2022 and is the fastest-growing segment during the forecast period.


• Simulab Corporation (US), Surgical Science (Sweden), Mentice (Sweden), VirtaMed AG (Switzerland), 3-Dmed Learning Through Simulation (US), Laerdal Medical (Norway), Gaumard Scientific (US), Materialise (Belgium), Stratasys (Israel), CAE Inc. (Canada)Simulab Corporation (US), Surgical Science (Sweden), Mentice (Sweden), VirtaMed AG (Switzerland), 3-Dmed Learning Through Simulation (US), Laerdal Medical (Norway), Gaumard Scientific (US), Materialise (Belgium), Stratasys (Israel), CAE Inc. (Canada) are the key players in the market.